Revelstoke Capital Partners Raises EPIC Fund III
07.20.22
This is only gets display when printing
Simpson Thacher represented Revelstoke Capital Partners in connection with the establishment of Revelstoke EPIC Fund III (“EPIC III”), a vehicle with $376 million of commitments formed to support the growth of one of Revelstoke’s portfolio companies, Rarebreed Veterinary Partners (“Rarebreed”). Concurrently with the closing of EPIC III, Rarebreed completed the acquisition of Revelstoke portfolio company Vet’s Best Friend.
Upon the combination with Vet’s Best Friend, Rarebreed now operates 118 hospitals in 11 states providing services spanning the full continuum of veterinary care, including general practice, urgent care, emergency and specialty.
The Simpson Thacher team included Tom Wuchenich, John Kreager, Bryon Boyce and Will McKenna (Funds); and Andrew Purcell and Caroline Phillips (Tax).